Bengaluru, India

Akshaya Kunjyannaya

This inventor holds 1 USPTO granted patent. Top assignee: Alkem Laboratories Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akshaya Kunjyannaya. Retrieved from https://idiyas.com/inventor/akshaya-kunjyannaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akshaya Kunjyannaya: Innovator in Pharmaceutical Chemistry

Introduction

Akshaya Kunjyannaya is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrug compounds. His innovative work has the potential to enhance the efficacy of existing medications.

Latest Patents

Kunjyannaya holds a patent for a compound titled "3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug." This invention relates to an atovaquone prodrug compound, which is synthesized through a process involving the condensation of Atovaquone with 5-methyl-4-chloromethyl dioxalone in a suitable solvent system. The process is designed to yield high purity and is suitable for large-scale manufacture.

Career Highlights

Kunjyannaya is currently associated with Alkem Laboratories Limited, a prominent player in the pharmaceutical industry. His work at Alkem Laboratories has allowed him to focus on innovative drug formulations and contribute to advancements in medical treatments.

Collaborations

He has collaborated with notable colleagues such as Sanjay Sukumar Saralaya and Shashiprabha, enhancing the research and development efforts within his team.

Conclusion

Akshaya Kunjyannaya's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patent for the atovaquone prodrug showcases his commitment to improving drug efficacy and manufacturing processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…